Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 61
- −5 vs. Q2 2023
- Portfolio value
- $900.7M
- −$46.2M (−4.9%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GSKGSK plc | ADR | 3,259,342 | $118.2M | 13.1% | +378,330+13.1% | Added | History |
| NTRANatera, Inc. | COM | 2,492,636 | $110.3M | 12.2% | +78,849+3.3% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 6,952,085 | $70.9M | 7.9% | −715,959−9.3% | Reduced | History |
| UTHRUnited Therapeutics Corp | COM | 267,903 | $60.5M | 6.7% | +7,505+2.9% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 193,018 | $38.3M | 4.3% | +110,573+134.1% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,596,245 | $37.7M | 4.2% | +406,513+18.6% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 110,073 | $27.1M | 3.0% | +29,348+36.4% | Added | History |
| TECHBIO-TECHNE Corp | COM | 385,889 | $26.3M | 2.9% | +43,252+12.6% | Added | History |
| DHRDanaher Corp | Stock | 103,784 | $25.7M | 2.9% | +439+0.4% | Added | History |
| HQYHealthequity, Inc. | COM | 338,516 | $24.7M | 2.7% | +338,516 | New | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 205,815 | $23.8M | 2.6% | −269,495−56.7% | Reduced | History |
| ILMNIllumina, Inc. | COM | 166,782 | $22.9M | 2.5% | +42,730+34.4% | Added | History |
| CYHCommunity Health Systems Inc | COM | 7,146,088 | $20.7M | 2.3% | −131,768−1.8% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 1,478,489 | $20.3M | 2.3% | −262,462−15.1% | Reduced | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 2,479,103 | $17.6M | 1.9% | +106,990+4.5% | Added | History |
| SWAVShockwave Medical, Inc. | COM | 84,462 | $16.8M | 1.9% | +64,324+319.4% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 588,143 | $16.2M | 1.8% | −197,597−25.1% | Reduced | History |
| CNCCentene Corp | Stock | 190,607 | $13.1M | 1.5% | +37,874+24.8% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 108,771 | $12.6M | 1.4% | +2,306+2.2% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 252,446 | $11.5M | 1.3% | +10,874+4.5% | Added | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 2,644,988 | $11.2M | 1.2% | −2,620,263−49.8% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 190,430 | $9.71M | 1.1% | −5,261−2.7% | Reduced | History |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 255,323 | $9.63M | 1.1% | +5,037+2.0% | Added | – |
| ELVElevance Health, Inc. | Stock | 21,694 | $9.45M | 1.0% | +19,379+837.1% | Added | History |
| LQDALiquidia Corp | COM NEW | 1,395,454 | $8.85M | 1.0% | +470,010+50.8% | Added | History |
| HUMHumana Inc | Stock | 18,121 | $8.82M | 1.0% | +6,194+51.9% | Added | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 8,431,875 | $7.76M | 0.9% | −2,070,234−19.7% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 443,270 | $6.80M | 0.8% | +443,270 | New | History |
| WATWaters Corp | COM | 23,124 | $6.34M | 0.7% | +12,196+111.6% | Added | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 660,618 | $6.11M | 0.7% | −31,751−4.6% | Reduced | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 1,453,378 | $5.70M | 0.6% | +1,453,378 | New | History |
| MCRBSeres Therapeutics, Inc. | COM | 2,352,556 | $5.60M | 0.6% | −724,200−23.5% | Reduced | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,705,774 | $5.39M | 0.6% | +1,705,774 | New | History |
| IFRXInflaRx N.V. | COM | 1,737,544 | $5.18M | 0.6% | −177,569−9.3% | Reduced | History |
| ICLRIcon PLC | COM | 20,998 | $5.17M | 0.6% | −50,728−70.7% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 286,748 | $4.78M | 0.5% | +172,089+150.1% | Added | History |
| AAgilent Technologies, Inc. | COM | 41,825 | $4.68M | 0.5% | +13,365+47.0% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 122,643 | $4.67M | 0.5% | +66,194+117.3% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 23,041 | $4.53M | 0.5% | +4,293+22.9% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 452,323 | $4.52M | 0.5% | +452,323 | New | History |
| PBYIPuma Biotechnology, Inc. | COM | 1,681,149 | $4.42M | 0.5% | +22,954+1.4% | Added | History |
| PNTGPennant Group, Inc. | COM | 365,899 | $4.07M | 0.5% | −65,723−15.2% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 12,234 | $4.01M | 0.4% | −9,020−42.4% | Reduced | History |
| GOSSGossamer Bio, Inc. | COM | 4,427,857 | $3.69M | 0.4% | +3,678,160+490.6% | Added | History |
| RVTYRevvity, Inc. | COM | 32,698 | $3.62M | 0.4% | +11,384+53.4% | Added | History |
| Curevac N VN2451R105 | COM | 516,794 | $3.53M | 0.4% | +159,452+44.6% | Added | – |
| BHVNBiohaven Ltd. | COM | 131,103 | $3.41M | 0.4% | 00.0% | Unchanged | History |
| PODDInsulet Corp | Stock | 21,299 | $3.40M | 0.4% | +21,299 | New | History |
| MRUSMerus N.V. | COM | 134,010 | $3.16M | 0.4% | +2,784+2.1% | Added | History |
| STROSutro Biopharma, Inc. | COM | 769,638 | $2.67M | 0.3% | +21,726+2.9% | Added | History |
| RGENRepligen Corp | COM | 16,153 | $2.57M | 0.3% | −49,914−75.6% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 4,565 | $2.24M | 0.2% | +411+9.9% | Added | History |
| MEDPMedpace Holdings, Inc. | COM | 8,823 | $2.14M | 0.2% | −6,741−43.3% | Reduced | History |
| AVTRAvantor, Inc. | COM | 84,495 | $1.78M | 0.2% | +84,495 | New | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 20,000 | $1.46M | 0.2% | +20,000 | New | – |
| XOMAXOMA Royalty Corp | COM NEW | 89,950 | $1.27M | 0.1% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 337,131 | $967.6K | 0.1% | −90,186−21.1% | Reduced | History |
| Affimed N VN01045108 | COM | 1,676,684 | $801.3K | 0.1% | 00.0% | Unchanged | – |
| JBIOJade Biosciences, Inc. | COM | 50,242 | $681.8K | 0.1% | 00.0% | Unchanged | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 101,918 | $493.3K | 0.1% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 124,589 | $355.1K | <0.1% | 00.0% | Unchanged | History |
Options (8)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $143.3M | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $102.6M | – |
| iShares Tr464287556 | ISHARES BIOTECH | $8.60M | – |
| iShares Tr464287432 | 20 YR TR BD ETF | $8.31M | – |
| iShares Tr464288513 | IBOXX HI YD ETF | $6.63M | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $5.84M | – |
| AMNAmn Healthcare Services Inc | COM | $4.26M | – |
| BBIOBridgeBio Pharma, Inc. | COM | $1.47M | – |
Sold out since Q2 2023 (13)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| CTLTCatalent, Inc. | COM | 356,875 | $15.5M | 1.6% | History |
| Abcam PLC000380204 | ADS | 499,394 | $12.2M | 1.3% | – |
| MODNModel N, Inc. | COM | 223,168 | $7.89M | 0.8% | History |
| XENEXenon Pharmaceuticals Inc. | COM | 171,378 | $6.60M | 0.7% | History |
| KURAKura Oncology, Inc. | COM | 450,622 | $4.77M | 0.5% | History |
| EHTHeHealth, Inc. | COM | 503,079 | $4.04M | 0.4% | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,327,857 | $2.93M | 0.3% | History |
| GOCOGoHealth, Inc. | CL A NEW | 104,820 | $2.07M | 0.2% | History |
| EOLSEvolus, Inc. | COM | 228,679 | $1.66M | 0.2% | History |
| ZLABZai Lab Ltd | ADR | 55,176 | $1.53M | 0.2% | History |
| URGNUroGen Pharma Ltd. | COM | 74,797 | $774.1K | 0.1% | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 48,788 | $326.9K | <0.1% | History |
| KYNBKyntra Bio, Inc. | COM | 5,600 | $15.1K | <0.1% | History |